PharmiWeb.com - Global Pharma News & Resources

Reports - Press Releases

Date Title Company
04-Nov-2025 NAYA Therapeutics to Present at the Network for Optimized Astatine-Labeled Radiopharmaceuticals (NOAR) Europe Annual Meeting ACCESS Newswire
04-Nov-2025 BioNxt Reports "Intention to Grant" Patent Notification from the European Patent Office for Its Oral Cladribine Sublingual Thin-Film as the Multiple Sclerosis Market Shifts Toward Patient-Friendly Therapies ACCESS Newswire
04-Nov-2025 Faron Announces Two Bexmarilimab Abstracts Accepted At Ash 2025, Including An Oral Presentation On Treatment Efficacy ACCESS Newswire
04-Nov-2025 Cellbxhealth PLC Announces Expert Consensus on CTCs; Update on Funding ACCESS Newswire
03-Nov-2025 FluoGuide A/S Issue Warrants to Board Members, Executive Management and Employees ACCESS Newswire
03-Nov-2025 Protagonist Therapeutics Announces Oral and Poster Presentations on Rusfertide at the 67th Annual ASH Meeting ACCESS Newswire
03-Nov-2025 FluoGuide A/S Completes Directed Share Issue of SEK 104 Million ACCESS Newswire
03-Nov-2025 The Assistance Fund Opens New Program for Macular Telangiectasia ACCESS Newswire
03-Nov-2025 Reprieve House Opens Silicon Valley's First Premium Detox Facility ACCESS Newswire
03-Nov-2025 FluoGuide A/S Intends to Carry Out a Directed Share Issue of Approximately SEK 100 Million ACCESS Newswire
03-Nov-2025 Medical Care Technologies, Inc (OTC PINK:MDCE) Announces Development of AI-Powered Wellness App Suite with Global Reach ACCESS Newswire
03-Nov-2025 BioInvent to Present Early Phase 2a Data from Ongoing Trial with Triple Combination of BI-1206, Rituximab, and Calquence in r/r NHL, at ASH 2025 ACCESS Newswire
03-Nov-2025 Nomination Committee Appointed in Respect of AGM 2026 in Alligator Bioscience AB ACCESS Newswire
03-Nov-2025 BioInvent to Present Updated Phase 2a BI-1808 Monotherapy Data in CTCL at ASH 2025 ACCESS Newswire
03-Nov-2025 CASI Pharmaceuticals Announces Upcoming Presentation of Clinical Results for CID-103 at the 67th American Society of Hematology (ASH) Annual Meeting ACCESS Newswire
03-Nov-2025 Altamira Therapeutics Announces Successful Nanoparticle-Based Delivery of DNA Molecules ACCESS Newswire
03-Nov-2025 Prolocor Announces Publication in Journal of Invasive Cardiology. Prolocor pFCG Test is a Powerful Prognostic Marker of Ischemic Risk Early After Myocardial Infarction (MI). ACCESS Newswire
03-Nov-2025 Nomination Committee for Senzime Annual General Meeting 2026 ACCESS Newswire
03-Nov-2025 Biohope Announces Collaboration to Advance Immunobiogram for Renal Transplant ACCESS Newswire
03-Nov-2025 "Prejuvenation" Surge: Dr. Shervin Naderi Reveals How Millennials and Gen X Are Delaying Aging - Without Surgery ACCESS Newswire